Clinical Trials Browser

Interventional × Cholangiocarcinoma of the Gallbladder × Everolimus × Clear all

NCT00949949 2017-01-12

Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy

Phase 1 Completed

GastrointestinalGenitourinaryOther solid neoplasm

Cholangiocarcinoma of the Gallbladder